Abstract
Japanese encephalitis (JE) is an acute viral encephalitis transmitted by mosquitoes, mainly Culex tritaeniorhyncus infected with JE virus. The ratio of asymptomatic to symptomatic infection is estimated to be 100:1–1000:1 (Vaughn and Hoke 1992). However, once symptoms develop, JE is a serious viral encephalitis with a high mortality rate and high percentage of neuropsychiatric sequelae (Hoke 1992; Monath and Heinz 1996; see chapter by Solomon and Vaughn, this volume). Japanese data during the past 20 years demonstrated that the mortality rate was 17%, 48% of the patients recovered with neuropsychiatric sequalae, and only 31% recovered completely (Matsunaga et al. 1999).
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Aihara H, Takasaki T, Matsutani T. Suzuki R, Kurane I (1998) Establishment and characterization of Japanese encephalitis virus-specific, human CD4+ T cell clones: flavivirus cross-reactivity, protein recognition and cytotoxic activity. J Virol 72: 8032–8036
Akiyama K, Ueki Y, Shiraishi H, Yamamoto H, Kobayashi M (1996) Japanese encephalitis virus neutralizing antibodies among vaccinated residents in Miyagi prefecture:Beijing-1 strain vaccine. Rinsho to Uirusu 24: 204–209 (in Japanese)
Ali A, Igarashi A, Paneru LR, Hasebe F, Morita K, Takagi M, Suwonkerd W, Tsuda Y, Wada Y (1995) Characterization of two Japanese encephalitis virus strains isolated in Thailand. Arch Virol 140: 1557–1575
Ali A, Igarashi A (1997) Antigenic and genetic variations among Japanese encephalitis virus strains belonging to genotype 1. Microbiol Immunol 41: 241–252
Chen HW, Pan CH, Liau Y, Jou W, Tsai CJ, Wu HJ, Lin YL, Tao MH (1999) Screening of protective antigens of Japanese encephalitis virus by DNA immunization: a comparative study with conventional viral vaccine. J Virol 73: 10137–10145
Edelman R, Schneider RJ, Chieowanich P, Pornpibul R, Voodhikul P (1975) The effect of dengue virus infection on the clinical sequelae of Japanese encephalitis: a one-year follow-up study in Thailand. Southeast Asian J Trop Med Public Health 6: 308–315
Gould EA, Buckley A (1989) Antibody-dependent enhancement of yellow fever and Japanese encephalitis virus neurovirulence. J Gen Virol 70: 1605–1608
Goverdham MK, Kulkarni AB, Gupta AK, Tupe CD, Rodrigus JJ (1992) Two way cross-protection between West Nile and Japanese encephalitis virus in bonnet macaques. Acta Virol 36: 277–283
Hammon WMcD, Sather GE (1956) Immunity of Hamsterts to West Nile and Murray Valley viruses following immunization with St. Louis and Japanese B. Proc Soc Exp Biol Med 91: 521–524
Heinz FX, Berge R, Tuma W (1983) A topological and functional model of epitopes on the structural glycoprotein of tick-borne encephalitis virus defined by monoclonal antibodies. Virology 126: 525–537
Henchal EA, Henchal LS, Schlessinger JJ (1988) Synergistic interactions of anti-NSI monoclonal antibodies protect passively immunized mice from lethal challenge with dengue 2 virus. J Gen Virol 69: 2101–2107
Hoke CH (1992) Encephalitis viruses belonging to the Families Flaviviridae, Togaviridae, and Bunyaviridae. In: Gorbach SL et al. (eds) Infectious Diseases. Philadelphia, W.B. Saunders Co. pp 1835–1842
Hoke CH, Nisalak A, Sangawhipa N, Jatanasen S, Laorakapongse T, Innis BL, Kotchasenee S, Gingrich JB, Latendresse J, Fukai K, Burke DS (1988) Protection against Japanese encephalitis by inactivated vaccines. N Engl J Med 319: 608–614
Hsu TC, Chow LP, Wei HY, Chen CL, Hsu ST, Huang CT, Kitaoka M, Sunaga H (1971) A completed field trial for an evaluation of the effectiveness of mouse-brain Japanese encephalitis vaccine. In: Hammon WM, Kitaoka M, Downs WG (eds) Immunization for Japanese encephalitis. Jgaku Shoin Ltd. Tokyo Japan. pp 258–265
Johnson RT, Burke DS, Elwell M (1985) Japanese encephalitis: immunocytochemical studies of viral antigen and inflammatory cells in fatal cases. Ann Neurol 18: 567–573
Juang RF, Okuno Y, Fukunaga T, Tadano M, Fukai K, Baba K, Tsuda N, Yamada A, Yabuuchi H (1983) Neutralizing antibody responses to Japanese encephalitis vaccine in children. Biken J 26: 25–34
Kanamitsu M, Hashimoto N, Urasawa S, Katsurada M, Kimura H (1970) A field trial with an improved Japanese encephalitis vaccine in nonendemic area of the disease. Biken J 13: 313–328
Kaufman BM, Summers PL, DuBois DR (1989) Monoclonal antibodies for dengue virus preM glycoprotein protect mice against lethal dengue infection. Am J Trop Med Hyg 41: 578–580
Kimura-Kuroda J, Yasui K (1988a) Protection of mice against Japanese encephalitis virus by passive administration of monoclonal antibodies. J Immunol 141: 3606–3610
Kimura-Kuroda J, Yasui K (1988b) Antigenic comparison of envelope protein E between Japanese encephalitis and some other flavivirus using monoclonal antibodies. J Gen Virol 40: 531–544
Kitano T, Oya A (1996) Japanese encephalitis vaccine. In: Arai Y, Asano T, Chino T, Katow S, Miyamura T, Nakamura R, Oya A, Sato H (eds) Vaccine handbook. Maruzen Ltd. Tokyo, Japan. pp 103–113
Konishi E, Pincus S, Fonseca BAL, Shope RE, Paoletti E, Mason PW (1991) Comparison of protective immunity elicited by recombinant vaccinia viruses that synthesize E or NSI of Japanese encephalitis virus. Virology 185: 401–410
Konishi E, Kurane I, Mason PW, Innis BL, Ennis FA (1995) Proliferative responses of human peripheral blood T lymphocytes against Japanese encephalitis antigens. Am J Trop Med Hyg 53: 278–283
Konishi E, Kurane I, Mason PW, Shope RE, Ennis FA (1997) Poxvirus-based Japanese encephalitis vaccine candidates induce JE virus-specific CD8+ cytotoxic T lymphocytes in mice. Virology 227: 353–360
Konishi E, Kurane I, Mason PW, Shope RE, Kanesa-thasan N, Smucny J, Hoke CH, Ennis FA (1998a) Induction of Japanese encephalitis virus-specific cytotoxic T lymphocytes in humans by Poxvirusbased JE vaccine candidates. Vaccine 8: 842–849
Konishi E, Yamaoka M. Win KS, Kurane I, Mason PW (1998b) Induction of Protective Immunity against Japanese encephalitis in mice by immunization with a plasmid encoding JE virus premembrane and envelope genes. J Virol 72: 4925–4939
Konishi E, Yamaoka M, Win KS, Kurane I, Takada K, Mason PW (1999) Anamnestic neutralizing antibody response is critical for protection of mice from challenge following vaccination with a plasmid encoding Japanese encephalitis virus premembrane and envelope genes. J Virol 73: 5527–5534
Ku CC, King CC, Lin CY, Hsu HC, Chen LY, Yueh YY, Chang GJJ (1994) Homologous and heterologous neutralization antibody responses after immunization with Japanese encephalitis vaccine among taiwan children. J Med Virol 44: 122–131
Lin YL, Chen LK, Liao CL, Yeh CT, Ma SH, Chen JL, Huang YL, Chen SS, Chiang HY (1998) DNA immunization with Japanese encephalitis virus nonstructural protein NSI elicits protective immunity in mice. J Virol 72: 191–200
Mackenzie JS (1999) The ecology of Japanese encephalitis virus in the Australian region. Clin Virol 27: 1–17
Mason P, Dalrymple JM, Gentry MK et al. (1989) Molecular characterization of a neutralizing domain of Japanese encephalitis virus structural glycoproteins. J Gen Virol 70: 2037–2049
Matsunaga Y, Yabe S, Taniguchi K, Nakayama M, Kurane I (1999) Current status of Japanese encephalitis in Japan. J Jap Assoc Infect Dis 73: 97–103 (in Japanese)
Minamitani M, Shinozaki T, Torii M, Tokimatsu A, Tabata E, Sakamoto H, Takayama N, Oya A, Ogata T, Takeda H, Shimizu H (1974) A new observation on Japanese encephalitis vaccine. Shonika Rinsho 27: 814–823 (in Japanese)
Monath TP, Heinz FX (1996) Flaviviruses. In: Fields BN, Knipe DM, Hawley PM (eds) Field’s Virology, 3rd ed. Philadelphia, Lippincott-Raven Publishers
Murali-Krishna K, Ravi V, Manjunath R (1998) Protection of adult but not newborn mice against lethal intracerebral challenge with Japanese encephalitis virus by adaptively transferred virus-specific cytotoxic T lymphocytes: requirement for L3T4 cells. J Gen Virol 77: 705–714
Nimmannitya S, Hutamai S, Kalayanarooj S, Rojanasuphot S (1995) A field study on Nakayama and Beijing strains of Japanese encephalitis vaccines. Southeast Asian J Trop Med Public Health 26: 689–693
Oya A (1966) Immunity and protection of epidemic in Japanese encephalitis. Naika 17: 905–909 (in Japanese)
Oya A (1988) Japanese encephalitis vaccine. Acta Pediatr Jpn 30: 175–184
Oya A, Okuno T (1975) Japanese encephalitis. In: Prsearcher’s association of the National Institute of Health (eds) Experimental Biology 2nd ed. PI24–162. Maruzen Press Ltd. Tokyo
Rey F, Harrison S, Heinz FX (1995) The envelope glycoprotein from tick-borne encephalitis virus at 2 A resolution. Nature 375: 291–198
Rice CM (1996) Flaviviridae: The viruses and their replication. In: Fields BN, Knipe DM, Hawley PM (eds) Field’s Virology, 3rd ed. Philadelphia, Lippincott-Raven Publishers
Schlessinger JJ, Brangriss NM, Walsh EE (1985) Protection against 17D yellow fever encephalitis in mice by passive transfer of monoclonal antibodies to the nonstructural glycoprotein gp48 and by active immunization with gp48. J Immunol 135: 2805–2809
Susilowati S, Okuno Y, Fukunaga T, Tadano M, Juang RF, Fukai K (1981) Neutralization antibody responses induced by Japanese encephalitis virus vaccine. Biken J 24: 137–145
Shyu WRH, Wabg YC, Chin C. Chen WJ (1997) Assessment of Neutralizing antibodies elicited by a vaccine ( Nakayama) strain of Japanese encephalitis virus in Taiwan. Epidemiol Infect 119: 79–83
Takada K, Masaki H, Konish, E. Takahashi M, Kurane I (2000) Definition of an epitope on Japanese encephalitis virus (JEV) envelope protein recognized by JEV-specific murine CD8+ cytotoxic T lymphocytes. Arch Virol 145: 523–534
Takei N, Tokumoto S. Segawa K (1982) Investigation of maintenance of neutralizing antibody to Japanese encephalitis virus among senior high school students. Kansenshogaku Zasshi 56: 1003–1011 (in Japanese)
Vaughn DW, Hoke CH (1992) The epidemiology of Japanese encephalitis: prospects for prevention. Epidemiol Rev 14: 197–221
Wills MR, Sil BK, Cao JX, Yu YX, Garrett DT (1992) Antigenic characterization of the live attenuated Japanese encephalitis vaccine virus SAI4–14–2: a comparison with isolates of the virus covering a wide geographic area. Vaccine 10: 861 – 872
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2002 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Kurane, I. (2002). Immune Responses to Japanese Encephalitis Virus. In: Mackenzie, J.S., Barrett, A.D.T., Deubel, V. (eds) Japanese Encephalitis and West Nile Viruses. Current Topics in Microbiology and Immunology, vol 267. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-59403-8_5
Download citation
DOI: https://doi.org/10.1007/978-3-642-59403-8_5
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-63966-1
Online ISBN: 978-3-642-59403-8
eBook Packages: Springer Book Archive